Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > We can expect a lot more...!
View:
Post by RelevantStock on Feb 18, 2021 9:16pm

We can expect a lot more...!

We have broken out of the 1.10 zone (and other levels after) with rapid buys of around 500-700k shares at most. I am expecting days with volume at least at 3-5M, maybe more, when we make the news for the launch of Aristotle, partnerships, revenue, etc. So happy of how we held this morning (and yesterday morning too). The new buyers here just arrived early for the front row tickets, much more to come.
Comment by InvrsContrarian on Feb 18, 2021 10:27pm
So from what we know is that most biotech companies trade 10-15 times P/E. With a solid 1.5 mill from 3rd quarter we can speculate that the 4th quarter will be slighter higher than that from the available info from Tripp. I think we are still undervalued from that one quarter (the 3rd period lol) alone by a 2 million Mkt cap shortage. Now bring out the big guns and watch the 4th quarter(sunden ...more  
Comment by RelevantStock on Feb 18, 2021 10:52pm
I believe Tripp repeated that Q4 (and even Q1 2021) continued on the same revenue "trajectory", meaning we could expect a substantial revenue increase once again in the next ER... I also believe the current stock price is a mix between a return to a fair valuation and growing confidence in people who already knew Stagezero. Aristotle, new partners and Q4 revenues are not baked into the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities